Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in NAFLD and T2DM
NCT00994682Phase 4Completed
- Sponsor
- University of Florida
- Start
- Dec 2008
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in Nonalcoholic steatohepatitis (NASH), type 2 diabetes mellitus (T2DM), sponsored by University of Florida. Started Dec 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00994682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994682.